BYRN Byrna Technologies Inc.
AI brief AI-written, not reviewed by a person
Latest period figures show cash and equivalents at 8,418,000 USD as of 2026-08-31, down from 9,436,000 USD as of 2026-05-31; stockholders’ equity sits at 55,119,000 USD on 2026-08-31, up from 56,983,000 USD on 2026-05-31; revenue for the trailing 12 months to 2025-11-30 is 118,120,000 USD, versus 85,756,000 USD for the prior year period. The most recent quarterly results include negative net income of -2,911,000 USD for the three months to 2026-08-31, and revenue of 15,296,000 USD in that quarter.
- Cash and equivalents declined from 9,436,000 USD (2026-05-31) to 8,418,000 USD (2026-08-31). [1]
- Stockholders’ equity was 55,119,000 USD as of 2026-08-31, down from 66,488,000 USD as of 2026-02-28 and up from 56,983,000 USD on 2026-05-31. [1]
- Revenue (year) for 12 months to 2025-11-30 was 118,120,000 USD, compared with 85,756,000 USD for 12 months to 2024-11-30. [1]
- Net income (year) for 12 months to 2025-11-30 was 9,687,000 USD, versus 12,792,000 USD for 2024-11-30. [1]
- Net income (quarter) for the three months to 2026-08-31 was -2,911,000 USD, with the three months to 2026-08-31 revenue of 15,296,000 USD. [1][2]
- Total assets were 64,583,000 USD as of 2026-08-31, down from 79,900,000 USD as of 2026-02-28 and up from 68,417,000 USD on 2026-05-31. [1]
- Total liabilities were 9,464,000 USD as of 2026-08-31, down from 13,412,000 USD as of 2026-02-28 and 18,731,000 USD as of 2025-11-30. [1]
Written by OpenVibe.AI from the SEC numbers and filings on this page, not reviewed by a person. Informational only; not investment advice. Written from figures and filings up to (gpt-5-nano-2025-08-07).
Observations
| Metric | Value | Observed | Source | Retrieved | Freshness |
|---|---|---|---|---|---|
| Revenue (quarter) (3 months to 2026-08-31) | 15,296,000 USD | sec-companyfacts | current | ||
| Revenue (year) (12 months to 2025-11-30) | 118,120,000 USD | sec-companyfacts | current | ||
| Net income (quarter) (3 months to 2026-08-31) | -2,911,000 USD | sec-companyfacts | current | ||
| Net income (year) (12 months to 2025-11-30) | 9,687,000 USD | sec-companyfacts | current | ||
| Operating income (quarter) (3 months to 2026-08-31) | -2,930,000 USD | sec-companyfacts | current | ||
| Operating income (year) (12 months to 2025-11-30) | 11,838,000 USD | sec-companyfacts | current | ||
| Diluted EPS (quarter) (3 months to 2026-08-31) | -0.13 USD/shares | sec-companyfacts | current | ||
| Diluted EPS (year) (12 months to 2025-11-30) | 0.4 USD/shares | sec-companyfacts | current | ||
| Operating cash flow (quarter) (3 months to 2026-02-28) | -4,424,000 USD | sec-companyfacts | current | ||
| Operating cash flow (year) (12 months to 2025-11-30) | -1,572,000 USD | sec-companyfacts | current | ||
| Total assets (at 2026-08-31) | 64,583,000 USD | sec-companyfacts | current | ||
| Total liabilities (at 2026-08-31) | 9,464,000 USD | sec-companyfacts | current | ||
| Stockholders' equity (at 2026-08-31) | 55,119,000 USD | sec-companyfacts | current | ||
| Cash and equivalents (at 2026-08-31) | 8,418,000 USD | sec-companyfacts | current | ||
| Shares outstanding (at 2026-10-08) | 23,404,754 shares | sec-companyfacts | current |
Context
No reviewed context has been published for BYRN. The observations and documents below are shown as their sources stated them.
Documents
Source freshness
| Source | Freshness | Last successful fetch | Stale after | Sources reports |
|---|---|---|---|---|
| SEC EDGAR: company financial facts (XBRL) sec-companyfacts | current | 10080 min | ok | |
| SEC EDGAR: latest XBRL filings sec-xbrl-filings | current | 45 min | healthy |
Watch this instrument
Sign in to add BYRN to a private watchlist or to get an alert when a new document or observation arrives.
Machine-readable: BYRN.json (the same data with every timestamp and source).
Information only — not investment advice; no trading here. OpenVibe.Trade holds no money or assets, takes no orders and gives no personal recommendations.